造血-话题@MedSci

#造血#

356篇内容 | 2656人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1494514, encodeId=5f6314945145b, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=NEJM：Ipilimumab治疗异基因造血干细胞移植（HSCT）后的复发初见成效, objectType=article, longId=72960, objectId=c6f7e296071, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f7e296071, replyNumber=0, likeNumber=77, createdTime=2016-07-18, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f7e296071, moduleTitle=NEJM：Ipilimumab治疗异基因造血干细胞移植（HSCT）后的复发初见成效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f7e296071)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494513, encodeId=65d314945137f, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=苯诱导白血病可能与对造血干细胞毒性作用有关, objectType=article, longId=72016, objectId=f77ce20163a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f77ce20163a, replyNumber=0, likeNumber=64, createdTime=2016-07-05, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f77ce20163a, moduleTitle=苯诱导白血病可能与对造血干细胞毒性作用有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f77ce20163a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494512, encodeId=f3bf1494512b1, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JCO：半相合造血干细胞移植可降低淋巴瘤患者的慢性GVHD风险, objectType=article, longId=71821, objectId=0326e182197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0326e182197, replyNumber=0, likeNumber=123, createdTime=2016-07-01, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0326e182197, moduleTitle=JCO：半相合造血干细胞移植可降低淋巴瘤患者的慢性GVHD风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0326e182197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494511, encodeId=7c38149451118, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Cell Stem Cell：发动造血干细胞的增殖“引擎”需要一关键分子, objectType=article, longId=71740, objectId=6ff3e1740e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ff3e1740e5, replyNumber=0, likeNumber=47, createdTime=2016-06-30, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ff3e1740e5, moduleTitle=Cell Stem Cell：发动造血干细胞的增殖“引擎”需要一关键分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ff3e1740e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494510, encodeId=6c60149451075, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Lancet：MS患者自体造血干细胞移植后免疫净化疗法的疗效研究, objectType=article, longId=70673, objectId=42c8e06738e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42c8e06738e, replyNumber=0, likeNumber=109, createdTime=2016-06-15, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42c8e06738e, moduleTitle=Lancet：MS患者自体造血干细胞移植后免疫净化疗法的疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42c8e06738e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494509, encodeId=f8b21494509da, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nat Biotechnol：新方法有望让造血干细胞移植更加安全, objectType=article, longId=70358, objectId=cf09e0358e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf09e0358e3, replyNumber=0, likeNumber=62, createdTime=2016-06-11, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf09e0358e3, moduleTitle=Nat Biotechnol：新方法有望让造血干细胞移植更加安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf09e0358e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494508, encodeId=944b1494508f4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=重磅消息: 国内学者首次在单细胞水平上追踪造血干细胞（HSC）的形成, objectType=article, longId=68776, objectId=c89768e769a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c89768e769a, replyNumber=0, likeNumber=63, createdTime=2016-05-22, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c89768e769a, moduleTitle=重磅消息: 国内学者首次在单细胞水平上追踪造血干细胞（HSC）的形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c89768e769a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494507, encodeId=997d149450e83, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nature：救命！科学家发现生长造血干细胞的新方法, objectType=article, longId=67437, objectId=aea26e4379d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aea26e4379d, replyNumber=0, likeNumber=69, createdTime=2016-05-05, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aea26e4379d, moduleTitle=Nature：救命！科学家发现生长造血干细胞的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aea26e4379d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494506, encodeId=b43c1494506ae, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nature：不同类型的骨髓血管协同调节造血, objectType=article, longId=67053, objectId=4ba96e05312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ba96e05312, replyNumber=0, likeNumber=59, createdTime=2016-04-24, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ba96e05312, moduleTitle=Nature：不同类型的骨髓血管协同调节造血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ba96e05312)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494505, encodeId=67b2149450521, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Eur J Cancer：免疫组化预测转移性乳腺癌接受大剂量化疗联合自体造血干细胞移植的生存率, objectType=article, longId=63966, objectId=cf186396664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf186396664, replyNumber=0, likeNumber=53, createdTime=2016-03-02, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf186396664, moduleTitle=Eur J Cancer：免疫组化预测转移性乳腺癌接受大剂量化疗联合自体造血干细胞移植的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf186396664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494504, encodeId=a8e314945043e, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nature：鉴别造血干细胞的特殊标志物, objectType=article, longId=63327, objectId=7cbc6332eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cbc6332eef, replyNumber=0, likeNumber=86, createdTime=2016-02-18, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cbc6332eef, moduleTitle=Nature：鉴别造血干细胞的特殊标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cbc6332eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494503, encodeId=9cfd149450363, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Cell Stem Cell：胎儿造血干细胞的产生离不开胆汁酸！, objectType=article, longId=62878, objectId=738f628e8f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=738f628e8f0, replyNumber=0, likeNumber=56, createdTime=2016-02-03, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=738f628e8f0, moduleTitle=Cell Stem Cell：胎儿造血干细胞的产生离不开胆汁酸！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=738f628e8f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494502, encodeId=4324149450265, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Lancet Oncol：抗胸腺细胞球蛋白（ATG）对接受造血干细胞移植的患者有益, objectType=article, longId=61196, objectId=f7d561196b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7d561196b4, replyNumber=0, likeNumber=0, createdTime=2015-12-28, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7d561196b4, moduleTitle=Lancet Oncol：抗胸腺细胞球蛋白（ATG）对接受造血干细胞移植的患者有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7d561196b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494501, encodeId=b372149450157, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Lancet Haematology：CMVPepVax疫苗对于异基因造血干细胞移植，初步临床效果较好, objectType=article, longId=61195, objectId=e96a6119573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e96a6119573, replyNumber=0, likeNumber=26, createdTime=2015-12-28, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e96a6119573, moduleTitle=Lancet Haematology：CMVPepVax疫苗对于异基因造血干细胞移植，初步临床效果较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e96a6119573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494500, encodeId=1455149450048, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JAMA：造血干细胞移植不适合用于治疗难治性克罗恩病, objectType=article, longId=60654, objectId=feaa606545c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feaa606545c, replyNumber=0, likeNumber=0, createdTime=2015-12-17, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feaa606545c, moduleTitle=JAMA：造血干细胞移植不适合用于治疗难治性克罗恩病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feaa606545c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494499, encodeId=460514944999d, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=EBioMed：经济学因素影响造血干细胞移植术后患者预后, objectType=article, longId=59783, objectId=7c9559e8387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c9559e8387, replyNumber=0, likeNumber=53, createdTime=2015-12-02, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c9559e8387, moduleTitle=EBioMed：经济学因素影响造血干细胞移植术后患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c9559e8387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494498, encodeId=cb191494498e2, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=中国科学家发现促造血功能植物分子, objectType=article, longId=59132, objectId=b2765913277, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2765913277, replyNumber=0, likeNumber=109, createdTime=2015-11-21, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2765913277, moduleTitle=中国科学家发现促造血功能植物分子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2765913277)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494497, encodeId=51d2149449e9a, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nature：新研究发现机体造血新工厂, objectType=article, longId=59079, objectId=56d6590e9b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56d6590e9b9, replyNumber=0, likeNumber=80, createdTime=2015-11-21, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56d6590e9b9, moduleTitle=Nature：新研究发现机体造血新工厂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56d6590e9b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494496, encodeId=f30614944961c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Science：造血干细胞分化研究，颠覆50年经典理论, objectType=article, longId=58497, objectId=b7645849e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7645849e55, replyNumber=0, likeNumber=54, createdTime=2015-11-09, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7645849e55, moduleTitle=Science：造血干细胞分化研究，颠覆50年经典理论, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7645849e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494495, encodeId=724814944951c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JCO：关注淋巴瘤患者自体造血干细胞移植后心脏损伤, objectType=article, longId=53657, objectId=ebbf5365e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebbf5365e93, replyNumber=0, likeNumber=67, createdTime=2015-07-24, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebbf5365e93, moduleTitle=JCO：关注淋巴瘤患者自体造血干细胞移植后心脏损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebbf5365e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血

2020-05-29

医者仁心 (审核中...)

前往app查看评论内容

#造血#

NEJM：Ipilimumab治疗异基因造血干细胞移植（HSCT）后的复发初见成效

2016-07-18

医者仁心 (审核中...)

前往app查看评论内容

#造血#

苯诱导白血病可能与对造血干细胞毒性作用有关

2016-07-05

医者仁心 (审核中...)

前往app查看评论内容

#造血#

JCO：半相合造血干细胞移植可降低淋巴瘤患者的慢性GVHD风险

2016-07-01

医者仁心 (审核中...)

前往app查看评论内容

#造血#

Cell Stem Cell：发动造血干细胞的增殖“引擎”需要一关键分子

2016-06-30

医者仁心 (审核中...)

前往app查看评论内容

#造血#

Lancet：MS患者自体造血干细胞移植后免疫净化疗法的疗效研究

2016-06-15

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nat Biotechnol：新方法有望让造血干细胞移植更加安全

2016-06-11

俅侠 (审核中...)

前往app查看评论内容

#造血#

重磅消息: 国内学者首次在单细胞水平上追踪造血干细胞（HSC）的形成

2016-05-22

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nature：救命！科学家发现生长造血干细胞的新方法

2016-05-05

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nature：不同类型的骨髓血管协同调节造血

2016-04-24

俅侠 (审核中...)

前往app查看评论内容

#造血#

Eur J Cancer：免疫组化预测转移性乳腺癌接受大剂量化疗联合自体造血干细胞移植的生存率

2016-03-02

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nature：鉴别造血干细胞的特殊标志物

2016-02-18

俅侠 (审核中...)

前往app查看评论内容

#造血#

Cell Stem Cell：胎儿造血干细胞的产生离不开胆汁酸！

2016-02-03

俅侠 (审核中...)

前往app查看评论内容

#造血#

Lancet Oncol：抗胸腺细胞球蛋白（ATG）对接受造血干细胞移植的患者有益

2015-12-28

俅侠 (审核中...)

前往app查看评论内容

#造血#

Lancet Haematology：CMVPepVax疫苗对于异基因造血干细胞移植，初步临床效果较好

2015-12-28

俅侠 (审核中...)

前往app查看评论内容

#造血#

JAMA：造血干细胞移植不适合用于治疗难治性克罗恩病

2015-12-17

俅侠 (审核中...)

前往app查看评论内容

#造血#

EBioMed：经济学因素影响造血干细胞移植术后患者预后

2015-12-02

俅侠 (审核中...)

前往app查看评论内容

#造血#

中国科学家发现促造血功能植物分子

2015-11-21

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nature：新研究发现机体造血新工厂

2015-11-21

俅侠 (审核中...)

前往app查看评论内容

#造血#

Science：造血干细胞分化研究，颠覆50年经典理论

2015-11-09

俅侠 (审核中...)

前往app查看评论内容

#造血#

JCO：关注淋巴瘤患者自体造血干细胞移植后心脏损伤

2015-07-24

科室
- - 订阅+
  - 更多科室
工具
服务